Chimera Investment (CIM)
(Delayed Data from NYSE)
$11.90 USD
+0.12 (1.02%)
Updated May 31, 2024 04:00 PM ET
After-Market: $11.90 0.00 (0.00%) 7:58 PM ET
1-Strong Buy of 5 1
C Value F Growth A Momentum F VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$11.90 USD
+0.12 (1.02%)
Updated May 31, 2024 04:00 PM ET
After-Market: $11.90 0.00 (0.00%) 7:58 PM ET
1-Strong Buy of 5 1
C Value F Growth A Momentum F VGM
Zacks News
Chimera Investment (CIM) Stock Moves -0.9%: What You Should Know
by Zacks Equity Research
In the latest trading session, Chimera Investment (CIM) closed at $7.70, marking a -0.9% move from the previous day.
What's in the Offing for Chimera (CIM) this Earnings Season?
by Zacks Equity Research
Volatility in the mortgage market and wider Agency MBS spreads are anticipated to have affected Chimera's (CIM) book value in Q1.
Earnings Preview: Chimera Investment (CIM) Q1 Earnings Expected to Decline
by Zacks Equity Research
Chimera (CIM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Chimera Investment (CIM) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Chimera Investment (CIM) closed at $7.43, marking a -1.46% move from the previous day.
Chimera Investment (CIM) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Chimera Investment (CIM) closed at $7.33 in the latest trading session, marking a +0.27% move from the prior day.
Chimera Investment (CIM) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Chimera Investment (CIM) closed at $7.48 in the latest trading session, marking a -0.53% move from the prior day.
Chimera Investment (CIM) Surges: Stock Moves 9.4% Higher
by Zacks Equity Research
Chimera Investment (CIM) saw a big move last session, as its shares jumped more than 9% on the day, amid huge volumes.
Are Investors Undervaluing Chimera Investment (CIM) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Top Ranked Value Stocks to Buy for April 7th
by Zacks Equity Research
Here are four stocks with buy rank and strong value characteristics for investors to consider today, April 7th
Top Ranked Income Stocks to Buy for April 7th
by Zacks Equity Research
Here are four stocks with buy rank and strong income characteristics for investors to consider today, April 7th
Chimera Investment Enters Oversold Territory
by Zacks Equity Research
Chimera Investment has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock.
Top Ranked Income Stocks to Buy for April 3rd
by Zacks Equity Research
Here are four stocks with buy rank and strong income characteristics for investors to consider today, April 3rd
The Zacks Analyst Blog Highlights: Enviva, MGM, Chimera, DCP and Teekay
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Enviva, MGM, Chimera, DCP and Teekay
Do Options Traders Know Something About Chimera (CIM) Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to Chimera (CIM) stock based on the movements in the options market lately.
5 High-Yield Stocks to Defy Coronavirus-Led Crisis in April
by Zacks Equity Research
With the steep rise in coronavirus cases, we have shortlisted five high-yield stocks that can offer sizable returns amid this crisis
AGNC Investment (AGNC) Issues Update Amid Coronavirus Mayhem
by Zacks Equity Research
AGNC Investment's (AGNC) leverage and liquidity levels benefit from its concerted efforts and the Fed's aggressive actions to support the mortgage market.
Chimera (CIM): Strong Industry, Solid Earnings Estimate Revisions
by Zacks Equity Research
Chimera (CIM) has seen solid earnings estimate revision activity over the past two months, and belongs to a strong industry as well.
4 REIT Stocks to Buy Amid Coronavirus-Induced Market Maelstrom
by Shuvra Shankar Dey
REITs are considered bond proxies for their high high-dividend paying nature. Their dependence on debt is a positive amid lower borrowing costs due to back-to-back rate cuts.
Top Ranked Income Stocks to Buy for March 20th
by Zacks Equity Research
Here are four stocks with buy rank and strong income characteristics for investors to consider today, March 20th
Chimera Investment Sees Hammer Chart Pattern: Time to Buy?
by Zacks Equity Research
Chimera Investment has been struggling lately, but the selling pressure may be coming to an end soon.
4 Dividend Stocks to Buy Amid Coronavirus-Led Recession Fear
by Shuvra Shankar Dey
Dividend-paying stocks with healthy yields are safe bets now as they have strong prospects, and provide a cushion against large swings in the market.
What Makes Chimera (CIM) a New Strong Buy Stock
by Zacks Equity Research
Chimera (CIM) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Top Ranked Income Stocks to Buy for March 11th
by Zacks Equity Research
Here are four stocks with buy rank and strong income characteristics for investors to consider today, March 11th
Top Ranked Income Stocks to Buy for March 10th
by Zacks Equity Research
Here are four stocks with buy rank and strong income characteristics for investors to consider today, March 10th
Top Rate-Sensitive, Coronavirus-Resistant Picks for You
by Shuvra Shankar Dey
The emergency rate cut, undoubtedly, brings REITs and Utilities at the forefront.